Royal Bank Of Canada Bristol Myers Squibb CO Transaction History
Royal Bank Of Canada
- $579 Billion
- Q3 2025
A detailed history of Royal Bank Of Canada transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Royal Bank Of Canada holds 12,844,321 shares of BMY stock, worth $601 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
12,844,321
Previous 14,140,126
9.16%
Holding current value
$601 Million
Previous $655 Million
11.5%
% of portfolio
0.1%
Previous 0.12%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,682Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...